{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T22:44:39Z","timestamp":1794091479140,"version":"4.8.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T00:00:00Z","timestamp":1658880000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T00:00:00Z","timestamp":1658880000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["62072143"],"award-info":[{"award-number":["62072143"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81271208"],"award-info":[{"award-number":["81271208"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s11011-022-01004-6","type":"journal-article","created":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T13:00:05Z","timestamp":1659099605000},"page":"2511-2520","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Role of the gut-microbiota-metabolite axis in the rotenone model of early-stage Parkinson's Disease"],"prefix":"10.1007","volume":"37","author":[{"given":"Zhenzhen","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruihua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanying","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8809-6523","authenticated-orcid":false,"given":"Lifen","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,27]]},"reference":[{"key":"1004_CR1","doi-asserted-by":"publisher","first-page":"S331","DOI":"10.3233\/JPD-191729","volume":"9","author":"T Brudek","year":"2019","unstructured":"Brudek T (2019) Inflammatory Bowel Diseases and Parkinson\u2019s Disease. J Parkinsons Dis 9:S331\u2013S344","journal-title":"J Parkinsons Dis"},{"key":"1004_CR2","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.3233\/JPD-179001","volume":"7","author":"H Braak","year":"2017","unstructured":"Braak H, Del Tredici K (2017) Neuropathological Staging of Brain Pathology in Sporadic Parkinson\u2019s disease: Separating the Wheat from the Chaff. J Parkinsons Dis 7:S71\u2013S85","journal-title":"J Parkinsons Dis"},{"key":"1004_CR3","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.taap.2017.01.019","volume":"319","author":"Q Cao","year":"2017","unstructured":"Cao Q, Qin L, Huang F et al (2017) Amentoflavone protects dopaminergic neurons in MPTP-induced Parkinson\u2019s disease model mice through PI3K\/Akt and ERK signaling pathways. Toxicol Appl Pharmacol 319:80\u201390","journal-title":"Toxicol Appl Pharmacol"},{"key":"1004_CR4","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1007\/s00415-012-6801-2","volume":"260","author":"MG Cersosimo","year":"2013","unstructured":"Cersosimo MG, Raina GB, Pecci C et al (2013) Gastrointestinal manifestations in Parkinson\u2019s disease: prevalence and occurrence before motor symptoms. J Neurol 260:1332\u20131338","journal-title":"J Neurol"},{"key":"1004_CR5","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nmeth.f.303","volume":"7","author":"JG Caporaso","year":"2010","unstructured":"Caporaso JG, Kuczynski J, Stombaugh J et al (2010) QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7:335\u2013336","journal-title":"Nat Methods"},{"key":"1004_CR6","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.neuroscience.2014.10.028","volume":"302","author":"N Dzamko","year":"2015","unstructured":"Dzamko N, Geczy CL, Halliday GM (2015) Inflammation is genetically implicated in Parkinson\u2019s disease. Neuroscience 302:89\u2013102","journal-title":"Neuroscience"},{"key":"1004_CR7","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.2741\/3820","volume":"16","author":"Z-L Dai","year":"2011","unstructured":"Dai Z-L, Wu G, Zhu W-Y (2011) Amino acid metabolism in intestinal bacteria: links between gut ecology and host health. Front Biosci (Landmark Ed) 16:1768\u20131786","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"175","key":"1004_CR8","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1006\/exnr.2002.7891","volume":"14","author":"R Deumens","year":"2002","unstructured":"Deumens R, Blokland A, Prickaerts J (2002) Modeling Parkinson\u2019s disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway. Exp Neurol 14(175):303\u2013317","journal-title":"Exp Neurol"},{"key":"1004_CR9","doi-asserted-by":"publisher","first-page":"708","DOI":"10.3390\/nu10060708","volume":"10","author":"S Gerhardt","year":"2018","unstructured":"Gerhardt S, Mohajeri MH (2018) Changes of Colonic Bacterial Composition in Parkinson\u2019s Disease and Other Neurodegenerative Diseases. Nutrients 10:708","journal-title":"Nutrients"},{"key":"1004_CR10","doi-asserted-by":"publisher","first-page":"13780","DOI":"10.1073\/pnas.0706625104","volume":"104","author":"DN Frank","year":"2007","unstructured":"Frank DN, St Amand AL, Feldman RA et al (2007) Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 104:13780\u201313785","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1004_CR11","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/mds.26942","volume":"35","author":"EM Hill-Burns","year":"2017","unstructured":"Hill-Burns EM, Debelius JW, Morton JT et al (2017) Parkinson\u2019s disease and Parkinson\u2019s disease medications have distinct signatures of the gut microbiome. Mov Disord 35:739\u2013749","journal-title":"Mov Disord"},{"key":"1004_CR12","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1111\/j.1471-4159.2006.04440.x","volume":"101","author":"M Inden","year":"2007","unstructured":"Inden M, Kitamura Y, Takeuchi H et al (2007) Neurodegeneration of mouse nigrostriatal dopaminergic system induced by repeated oral administration of rotenone is prevented by 4-phenylbutyrate, a chemical chaperone. J Neurochem 101:1491\u20131504","journal-title":"J Neurochem"},{"key":"1004_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2019.113159","volume":"325","author":"DN Koutzoumis","year":"2020","unstructured":"Koutzoumis DN, Vergara M, Pino J et al (2020) Alterations of the gut microbiota with antibiotics protects dopamine neuron loss and improve motor deficits in a pharmacological rodent model of Parkinson\u2019s disease. Exp Neurol 325:113159","journal-title":"Exp Neurol"},{"key":"1004_CR14","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","volume":"103","author":"S Kim","year":"2019","unstructured":"Kim S, Kwon S-H, Kam T-I et al (2019) Transneuronal Propagation of Pathologic \u03b1-Synuclein from the Gut to the Brain Models Parkinson\u2019s Disease. Neuron 103:627\u2013641","journal-title":"Neuron"},{"key":"1004_CR15","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1002\/mds.26307","volume":"30","author":"A Keshavarzian","year":"2015","unstructured":"Keshavarzian A, Green SJ, Engen PA et al (2015) Colonic bacterial composition in Parkinson\u2019s disease. Mov Disord 30:1351\u20131360","journal-title":"Mov Disord"},{"key":"1004_CR16","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1007\/s11064-018-2620-x","volume":"43","author":"F Lai","year":"2018","unstructured":"Lai F, Jiang R, Xie W et al (2018) Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson\u2019s Disease. Neurochem Res 43:1986\u20131999","journal-title":"Neurochem Res"},{"key":"1004_CR17","doi-asserted-by":"publisher","first-page":"13888","DOI":"10.1038\/srep13888","volume":"5","author":"H Luan","year":"2015","unstructured":"Luan H, Liu L-F, Tang Z et al (2015) Comprehensive urinary metabolomic profiling and identification of potential noninvasive marker for idiopathic Parkinson\u2019s disease. Sci Rep 5:13888","journal-title":"Sci Rep"},{"key":"1004_CR18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cbi.2014.09.006","volume":"223","author":"Z Lu","year":"2014","unstructured":"Lu Z, Wang J, Li M et al (2014) 1)H NMR-based metabolomics study on a goldfish model of Parkinson\u2019s disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP. Chem Biol Interact 223:18\u201326","journal-title":"Chem Biol Interact"},{"key":"1004_CR19","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1021\/cb400894a","volume":"9","author":"S Lei","year":"2014","unstructured":"Lei S, Zavala-Flores L, Garcia-Garcia A et al (2014) Alterations in energy\/redox metabolism induced by mitochondrial and environmental toxins: a specific role for glucose-6-phosphate-dehydrogenase and the pentose phosphate pathway in paraquat toxicity. ACS Chem Biol 9:2032\u20132048","journal-title":"ACS Chem Biol"},{"key":"1004_CR20","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1093\/brain\/awx133","volume":"140","author":"MK Mamik","year":"2017","unstructured":"Mamik MK, Power C (2017) CInflammasomes in neurological diseases: emerging pathogenic and therapeutic concepts. Brain 140:2273\u20132285","journal-title":"Brain"},{"key":"1004_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3389\/fnsys.2013.00009","volume":"7","author":"M Matsumoto","year":"2013","unstructured":"Matsumoto M, Kibe R, Ooga T et al (2013) Cerebral low-molecular metabolites influenced by intestinal microbiota: a pilot study. Front Syst Neurosci 7:9","journal-title":"Front Syst Neurosci"},{"key":"1004_CR22","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1113\/jphysiol.2001.013147","volume":"539","author":"M Mori","year":"2002","unstructured":"Mori M, G\u00e4hwiler BH, Gerber U (2002) Beta-alanine and taurine as endogenous agonists at glycine receptors in rat hippocampus in vitro. J Physiol 539:191\u2013200","journal-title":"J Physiol"},{"key":"1004_CR23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0022-510X(97)00069-5","volume":"150","author":"JA Molina","year":"1997","unstructured":"Molina JA, Jim\u00e9nez-Jim\u00e9nez FJ, Gomez P et al (1997) Decreased cerebrospinal fluid levels of neutral and basic amino acids in patients with Parkinson\u2019s disease. J Neurol Sci 150:123\u2013127","journal-title":"J Neurol Sci"},{"key":"1004_CR24","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41583-020-00381-0","volume":"21","author":"BD Needham","year":"2020","unstructured":"Needham BD, Kaddurah-Daouk R, Mazmanian SK (2020) Gut microbial molecules in behavioural and neurodegenerative conditions. Nat Rev Neurosci 21:717\u2013731","journal-title":"Nat Rev Neurosci"},{"key":"1004_CR25","first-page":"435","volume":"50","author":"N Ogawa","year":"1985","unstructured":"Ogawa N, Hirose Y, Ohara S et al (1985) A simple quantitative bradykinesia test in MPTP-treated mice. Res Commun Chem Pathol Pharmacol 50:435\u2013441","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"1004_CR26","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0065-2164(08)00605-9","volume":"65","author":"CP O'Byrne","year":"2008","unstructured":"O\u2019Byrne CP, Karatzas KAG et al (2008) The role of sigma B (sigma B) in the stress adaptations of Listeria monocytogenes: overlaps between stress adaptation and virulence. Adv Appl Microbiol 65:115\u2013140","journal-title":"Adv Appl Microbiol"},{"key":"1004_CR27","doi-asserted-by":"publisher","first-page":"799","DOI":"10.3920\/BM2017.0202","volume":"9","author":"P Perez-Pardo","year":"2018","unstructured":"Perez-Pardo P, Dodiya HB, Engen PA et al (2018) NGut bacterial composition in a mouse model of Parkinson\u2019s disease. Benef Microbes 9:799\u2013814","journal-title":"Benef Microbes"},{"key":"1004_CR28","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1007\/s10517-017-3700-7","volume":"162","author":"VA Petrov","year":"2017","unstructured":"Petrov VA, Saltykova IV, Zhukova IA et al (2017) Analysis of Gut Microbiota in Patients with Parkinson\u2019s Disease. Bull Exp Biol Med 162:734\u2013737","journal-title":"Bull Exp Biol Med"},{"key":"1004_CR29","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/srep00898","volume":"2","author":"F Pan-Montojo","year":"2012","unstructured":"Pan-Montojo F, Schwarz M, Winkler C et al (2012) Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice. Sci Rep 2:898","journal-title":"Sci Rep"},{"key":"1004_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008762","volume":"5","author":"F Pan-Montojo","year":"2010","unstructured":"Pan-Montojo F, Anichtchik O, Dening Y et al (2010) Progression of Parkinson\u2019s disease pathology is reproduced by intragastric administration of rotenone in mice. PLoS ONE 5:e8762","journal-title":"PLoS ONE"},{"key":"1004_CR31","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.bbi.2018.02.016","volume":"70","author":"Y Qian","year":"2018","unstructured":"Qian Y, Yang X, Xu S et al (2018) Alteration of the fecal microbiota in Chinese patients with Parkinson\u2019s disease. Brain Behav Immun 70:194\u2013202","journal-title":"Brain Behav Immun"},{"key":"1004_CR32","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.2584","volume":"4","author":"T Rognes","year":"2016","unstructured":"Rognes T, Flouri T, Nichols B et al (2016) VSEARCH: a versatile open source tool for metagenomics. Peer J 4:e2584","journal-title":"Peer J"},{"key":"1004_CR33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/MCO.0b013e32835acaf4","volume":"16","author":"CK Rayner","year":"2013","unstructured":"Rayner CK, Horowitz M (2013) Physiology of the ageing gut. Curr Opin Clin Nutr Metab Care 16:33\u201338","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"1004_CR34","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.arr.2018.04.004","volume":"45","author":"M-F Sun","year":"2018","unstructured":"Sun M-F, Shen Y-Q (2018) Dysbiosis of gut microbiota and microbial metabolites in Parkinson\u2019s Disease. Ageing Res Rev 45:53\u201361","journal-title":"Ageing Res Rev"},{"key":"1004_CR35","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","volume":"167","author":"TR Sampson","year":"2016","unstructured":"Sampson TR, Debelius JW, Thron T et al (2016) Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson\u2019s Disease. Cell 167:1469\u20131480","journal-title":"Cell"},{"key":"1004_CR36","doi-asserted-by":"publisher","first-page":"549","DOI":"10.3233\/JPD-140389","volume":"4","author":"M Trupp","year":"2014","unstructured":"Trupp M, Jonsson P, Ohrfelt A et al (2014) Metabolite and peptide levels in plasma and CSF differentiating healthy controls from patients with newly diagnosed Parkinson\u2019s disease. J Parkinsons Dis 4:549\u2013560","journal-title":"J Parkinsons Dis"},{"key":"1004_CR37","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1039\/C5MB00711A","volume":"12","author":"A Wuolikainen","year":"2016","unstructured":"Wuolikainen A, Jonsson P, Ahnlund M et al (2016) Multi-platform mass spectrometry analysis of the CSF and plasma metabolomes of rigorously matched amyotrophic lateral sclerosis, Parkinson\u2019s disease and control subjects. Mol Biosyst 12:1287\u20131298","journal-title":"Mol Biosyst"},{"key":"1004_CR38","doi-asserted-by":"publisher","first-page":"5261","DOI":"10.1128\/AEM.00062-07","volume":"73","author":"Q Wang","year":"2007","unstructured":"Wang Q, Garrity GM, Tiedje JM et al (2007) Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol 73:5261\u20135267","journal-title":"Appl Environ Microbiol"},{"key":"1004_CR39","first-page":"803","volume":"45","author":"K Williams","year":"1994","unstructured":"Williams K, Zappia AM, Pritchett DB et al (1994) Sensitivity of the N-methyl-D-aspartate receptor to polyamines is controlled by NR2 subunits. Mol Pharmacol 45:803\u2013809","journal-title":"Mol Pharmacol"},{"key":"1004_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2021.105187","volume":"160","author":"Z Yan","year":"2021","unstructured":"Yan Z, Yang F, Cao J et al (2021) Alterations of gut microbiota and metabolome with Parkinson\u2019s disease. Microb Pathog 160:105187","journal-title":"Microb Pathog"},{"key":"1004_CR41","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3389\/fnagi.2017.00441","volume":"9","author":"X Yang","year":"2018","unstructured":"Yang X, Qian Y, Xu S et al (2018) Longitudinal Analysis of Fecal Microbiome and Pathologic Processes in a Rotenone Induced Mice Model of Parkinson\u2019s Disease. Front Aging Neurosci 9:441","journal-title":"Front Aging Neurosci"},{"key":"1004_CR42","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1128\/JB.01038-09","volume":"192","author":"L Zhu","year":"2010","unstructured":"Zhu L, Peng Q, Song F et al (2010) Structure and regulation of the gab gene cluster, involved in the gamma-aminobutyric acid shunt, are controlled by a sigma54 factor in Bacillus thuringiensis. J Bacteriol 192:346\u2013355","journal-title":"J Bacteriol"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-022-01004-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-022-01004-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-022-01004-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T06:16:53Z","timestamp":1666160213000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-022-01004-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,27]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["1004"],"URL":"https:\/\/doi.org\/10.1007\/s11011-022-01004-6","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,27]]},"assertion":[{"value":"21 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the First Affiliated Hospital of Harbin Medical University (No 201985).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}